InvestorsHub Logo
Followers 516
Posts 38725
Boards Moderated 5
Alias Born 04/26/2012

Re: None

Sunday, 09/25/2016 10:23:02 AM

Sunday, September 25, 2016 10:23:02 AM

Post# of 50178
http://www.arrayit.com/

There is absolutely no reason why Arrayit (ARYC) should not be trading at $.25 or more per share currently

$24.4 million dollar contract just signed by Arrayit this week and shares are for sale at .0012!!!

Arrayit Corporation (ARYC) leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. - Powerful Science for Life™

ARYC share price has bottomed and a small investment of $5000 could net a return of $100,000 to $500,000. Don't miss opportunity my friends.


Arrayit signs 3-year $24.4 million patented microarray technology sales and marketing agreement with a leading laboratory services provider.
Arrayit reports record blood card sales in Q3-16 on microarray immunoassay research apps http://www.arrayit.com/Produc

Arrayit customers in Tel Aviv Israel use Arrayit microarray technology to publish bioprosthetic heart valve advance
http://
onlinelibrary.wiley.com/doi/10.1111/xe
n.12260/full

Arrayit quotes $160,000 microarray platform to molecular diagnostic leader Akonni Biosystems http://www.akonni.com

Arrayit reports $18,500 microarray platform sale life sciences leader ChemBio Moscow Russia
?http://www.?
?chembio.ru?



Arrayit reports $34500 SpotBot 4 Microarray platform sale, leading European Distributor Grupo Taper Sintra Portugal http://www.arrayit.com/Products/Microarrayers/Microarrayer/microarrayer.html

Arrayit reports microarray sale to testing leader RDL Reference Laboratory Los Angeles CA http://www.rdlinc.com

Arrayit ships $40,000 microarray platform life sciences leader Daemyung Sciences Seoul Korea http://www.dm4you.com
Arrayit signs 3-year $24.4 million patented microarray technology sales and marketing agreement with a leading laboratory services provider.

Arrayit customers from Arizona State use Arrayit microarray technology to publish adult stem cell therapy advance
http://www.
sciencedirect.com/science/articl
e/pii/S1873506115000598


Can an antibody microarray made with Arrayit technology replace in-situ hybs in HER2 breast cancer diagnostics?...
?http://?
?fb.me/2Xx9b1Oom?








Arrayit reports $30,000 microarray services sale to a top research

Arrayit quotes $179,430 microarrays to biomedical leader Progenie Molecular Valencia España http://www.progenie-molecular.com

Arrayit quotes $51,680 microarrays to top leader De La Salle University Manila Philippines http://www.dlsu.edu.ph

Arrayit quotes $102,240 microarray platform to venture think tank Leading Technology Group http://www.leadingtechnology.co

Arrayit quotes $38,485 microarray platform to top Korean distributor Daemyung Science Seoul http://www.dm4you.com
Arrayit Corporation ?@arrayit
Arrayit completes conference call on huge DNA testing opportunity in massive market in India http://arrayit.com/Services/SNP_Genotyping/snp_genotyping.html

Arrayit reports DNA testing inquiry from top agency in India. Market penetration of 0.1% would produce $48M revenues http://arrayit.com/Services/SNP_Genotyping/snp_genotyping.html

Arrayit Corporation ?@arrayit
Arrayit quotes $235,000 microarray instruments to top lab University Ottawa Ontario Canada http://www.uottawa.ca

Arrayit reports microarray sale to advanced technology leaders Waki Company Tokyo Japan http://waki-bg.jp

Arrayit reports microarray sale to automated molecular testing leader AutoGenomics Vista CA http://www.autogenomics.com

Arrayit reports microarray sale to life sciences European Biotech Network Dolembreux Belgium http://www.euro-bio-net.com

Arrayit reports microarray sale to top medical researcher at $13.4B endowed MIT Cambridge MA http://web.mit.edu



Arrayit expands marketing on $100K+ TissueMax™ Automated and Personal Tissue Microarrayers


Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.